Updated:
Trumed Investment Management
Trumed Investment Management was formed in 2012 as the dedicated investment vehicle for the family behind Troyka Holdings, one of Nigeria’s largest...
Trumed Investment Management
Trumed Investment Management was formed in 2012 as the dedicated investment vehicle for the family behind Troyka Holdings, one of Nigeria’s largest integrated healthcare and pharmaceutical distribution groups. The firm formalized what had previously been a set of direct investments made from the operating company’s balance sheet, creating an institutional structure to manage a long-term portfolio distinct from the core distribution business. The wealth originates from decades of pharmaceutical importation, manufacturing, and logistics across Nigeria and the broader Economic Community of West African States region. The firm deploys capital across healthcare services, commercial real estate, and private credit opportunities in Nigeria and select West African markets. Its healthcare investments extend the family’s operating expertise into adjacent verticals — diagnostics chains, specialized clinics, and health-tech platforms that complement the distribution network. In real estate, the firm has backed medical-office developments and mixed-use commercial properties in Lagos and Abuja. The credit book includes structured receivables financing for pharmaceutical wholesalers and short-term bridge facilities for real estate developers, leveraging the family’s deep relationships across the healthcare supply chain to originate deal flow that institutional lenders often miss. Trumed operates from Lagos with a lean team, drawing on the operating executives of Troyka Holdings for due diligence and post-investment oversight — a model that blurs the line between family office and strategic corporate venture arm. The firm does not publicly disclose assets under management or total deployment figures. In September 2023, the group’s pharmaceutical manufacturing subsidiary secured a $10 million expansion facility from a development finance institution to increase local production capacity, a move that indirectly strengthens the investment arm’s healthcare ecosystem (per public record, 2023). What distinguishes Trumed from other Nigerian family offices is its refusal to raise third-party capital or syndicate deals, maintaining a fully proprietary balance sheet funded exclusively by retained operating earnings. This permanent capital structure allows the firm to hold assets indefinitely without the pressure of fund-life constraints, making it a quiet but persistent competitor to private equity funds targeting the same healthcare and real-estate segments in Nigeria’s lower-middle market.
General information
Firm type
Single Family Office
Year founded
2012
AUM
Undisclosed
Location
Region
Africa
Country
Nigeria
City
Lagos
Corporate office
Lagos, Nigeria
Principals
Troyka Holdings
Parent entity
Sector focus
Frequently asked questions
Where does Trumed Investment Management's capital come from?
The firm manages capital generated by Troyka Holdings, a Nigerian pharmaceutical distribution and manufacturing group. The family wealth was built over decades in healthcare logistics, drug importation, and local production across Nigeria and West Africa. Trumed does not accept outside investors or manage third-party capital.
How does Trumed source its investment opportunities?
Trumed relies heavily on the operating relationships of its parent group, Troyka Holdings, to identify healthcare and credit opportunities that other investors cannot access. The firm originates structured receivables deals by working directly with pharmaceutical wholesalers in the Troyka supply chain, and identifies real estate projects through the family's long-standing developer relationships in Lagos and Abuja. This origination model is relationship-intensive and does not depend on auction processes or intermediary-led deal flow.
Does Trumed make fund commitments or only direct investments?
Available public information suggests Trumed operates almost exclusively through direct investments and structured credit deals rather than committing capital as a limited partner to third-party funds. The firm has not disclosed any fund-of-funds activity, consistent with its preference for controlling or deeply influencing the assets it holds.
What investment stages does Trumed typically target?
Trumed targets growth-stage healthcare companies and operating businesses where the Troyka group's distribution infrastructure can accelerate commercial traction. In real estate, the firm participates in both development-stage and income-producing assets. The structured credit book tends toward short-duration, asset-backed facilities for counter-parties already known to the family.
Is Trumed structured as a single family office or a corporate venture arm?
Trumed occupies a hybrid position. Legally it is a separate investment management entity, but it draws due-diligence and operational support from executives within Troyka Holdings. This embedded structure allows it to evaluate healthcare investments with an operator's lens rather than a purely financial one, making it function more like a strategic corporate venture platform than a conventional single family office.
Does Trumed invest outside of Nigeria?
Trumed has indicated an investment mandate covering West Africa, and its parent group's distribution network reaches multiple countries in the Economic Community of West African States. Specific investments in Ghana, Côte d'Ivoire, or other regional markets have not been publicly detailed, but the stated geographic focus extends beyond Nigeria.
Which sectors does Trumed explicitly avoid?
There is no public statement of excluded sectors, but the firm's disclosed activity concentrates narrowly on healthcare verticals, real estate, and structured credit. Energy, consumer goods outside the health sector, and technology platforms without a healthcare distribution angle do not appear in the firm's known portfolio, suggesting a deliberate avoidance of sectors where the family lacks an operating edge.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: